SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-017341
Filing Date
2022-06-16
Accepted
2022-06-16 14:49:04
Documents
3
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165540533246982.html 4  
1 FORM 4 wf-form4_165540533246982.xml 4 3875
2 POWER OF ATTORNEY ex-24.htm EX-24 3160
3 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS poastephendavis7-13x2015.htm EX-24 3305
  Complete submission text file 0001628280-22-017341.txt   11824
Mailing Address ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 221020270

Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations